Home › Funds › Krensavage Asset Management, LLC › SUPN
Krensavage Asset Management, LLC position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
Krensavage Asset Management, LLC reported holding 280,681 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$13.1M, representing 4.96% of its reported portfolio and ranking #8 among its reported holdings. Krensavage Asset Management, LLC has disclosed SUPN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Krensavage Asset Management, LLC's SUPN position evolved
Krensavage Asset Management, LLC first disclosed a stake in SUPN in Q1 2025 at 431,986 shares (US$14.1M). The position peaked in Q3 2025 at 363,479 shares, worth US$17.4M. Across 6 filings, Krensavage Asset Management, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 280,681 shares valued at US$13.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 431.99K | $14.15M | New |
| Q2 2025 | 472.38K | $14.89M | Add |
| Q3 2025 | 363.48K | $17.37M | Reduce |
| Q4 2025 | 313.50K | $15.58M | Reduce |
| Q1 2026 | 280.68K | $14.51M | Reduce |
| Q2 2026 | 280.68K | $13.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SUPN and 13F data
SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 35 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SUPN
- MILLENNIUM MANAGEMENT LLC 3.85M sh · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M sh · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M sh · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K sh · $28.55M · Q2 2026
- Soleus Capital Management, L.P. 520.00K sh · $24.19M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K sh · $22.80M · Q2 2026
More on Krensavage Asset Management, LLC
FAQ
How long has Krensavage Asset Management, LLC held SUPN?
Krensavage Asset Management, LLC has disclosed SUPN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Krensavage Asset Management, LLC's current position in SUPN?
As of Q2 2026, Krensavage Asset Management, LLC holds 280.68K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $13.05M, representing 4.96% of its reported portfolio and ranking #8.
Has Krensavage Asset Management, LLC been buying or selling SUPN?
In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in SUPN. The position peaked in Q3 2025 at 363.48K shares.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.